Dermatomyositis and Paclitaxel-Induced Cutaneous Drug Eruption Associated with Metastatic Breast Cancer

Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with several human malignancies, especially breast cancer. Paclitaxel is a taxane antineoplastic agent with therapeutic effects against a wide range...

Full description

Saved in:
Bibliographic Details
Published inJournal of breast cancer Vol. 18; no. 2; pp. 195 - 199
Main Authors Kim, Youngji, Jung, Woojin, Park, Yeon Hee
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Breast Cancer Society 01.06.2015
한국유방암학회
Subjects
Case Report
일반외과학
Drug eruptions
Breast neoplasms
Immunity
Dermatomyositis
Paclitaxel
Online AccessGet full text
ISSN1738-6756
2092-9900
DOI10.4048/jbc.2015.18.2.195

Cover

Abstract Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with several human malignancies, especially breast cancer. Paclitaxel is a taxane antineoplastic agent with therapeutic effects against a wide range of cancers including breast cancer. This drug is well known for neurotoxicity and hypersensitivity reactions. However, cutaneous drug eruptions, especially those of grade III or higher, are not frequent. Here, we describe the case of a 55-year-old woman with metastatic breast cancer who developed paraneoplastic DM and a paclitaxel-induced exanthematous drug eruption. This case report emphasizes the importance of evaluating internal malignancies, such as advanced breast cancer, in newly developed DM patients. In addition, it presents a rare case of paclitaxel-induced exanthematous drug eruption. The purpose of this case report highlights the immunological pathogenic mechanism of DM and drug eruption in underlying advanced breast cancer.
AbstractList Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with several human malignancies, especially breast cancer. Paclitaxel is a taxane antineoplastic agent with therapeutic effects against a wide range of cancers including breast cancer. This drug is well known for neurotoxicity and hypersensitivity reactions. However, cutaneous drug eruptions, especially those of grade III or higher, are not frequent. Here, we describe the case of a 55-year-old woman with metastatic breast cancer who developed paraneoplastic DM and a paclitaxel-induced exanthematous drug eruption. This case report emphasizes the importance of evaluating internal malignancies, such as advanced breast cancer, in newly developed DM patients. In addition, it presents a rare case of paclitaxel-induced exanthematous drug eruption. The purpose of this case report highlights the immunological pathogenic mechanism of DM and drug eruption in underlying advanced breast cancer.Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with several human malignancies, especially breast cancer. Paclitaxel is a taxane antineoplastic agent with therapeutic effects against a wide range of cancers including breast cancer. This drug is well known for neurotoxicity and hypersensitivity reactions. However, cutaneous drug eruptions, especially those of grade III or higher, are not frequent. Here, we describe the case of a 55-year-old woman with metastatic breast cancer who developed paraneoplastic DM and a paclitaxel-induced exanthematous drug eruption. This case report emphasizes the importance of evaluating internal malignancies, such as advanced breast cancer, in newly developed DM patients. In addition, it presents a rare case of paclitaxel-induced exanthematous drug eruption. The purpose of this case report highlights the immunological pathogenic mechanism of DM and drug eruption in underlying advanced breast cancer.
Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with several human malignancies, especially breast cancer. Paclitaxel is a taxane antineoplastic agent with therapeutic effects against a wide range of cancers including breast cancer. This drug is well known for neurotoxicity and hypersensitivity reactions. However, cutaneous drug eruptions, especially those of grade III or higher, are not frequent. Here, we describe the case of a 55-year-old woman with metastatic breast cancer who developed paraneoplastic DM and a paclitaxel-induced exanthematous drug eruption. This case report emphasizes the importance of evaluating internal malignancies, such as advanced breast cancer, in newly developed DM patients. In addition, it presents a rare case of paclitaxel-induced exanthematous drug eruption. The purpose of this case report highlights the immunological pathogenic mechanism of DM and drug eruption in underlying advanced breast cancer.
Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with several human malignancies, especially breast cancer. Paclitaxel is a taxane antineoplastic agent with therapeutic effects against a wide range of cancers including breast cancer. This drug is well known for neurotoxicity and hypersensitivity reactions. However, cutaneous drug eruptions, especially those of grade III or higher, are not frequent. Here, we describe the case of a 55-year-old woman with metastatic breast cancer who developed paraneoplastic DM and a paclitaxel-induced exanthematous drug eruption. This case report emphasizes the importance of evaluating internal malignancies, such as advanced breast cancer, in newly developed DM patients. In addition, it presents a rare case of paclitaxel-induced exanthematous drug eruption. The purpose of this case report highlights the immunological pathogenic mechanism of DM and drug eruption in underlying advanced breast cancer. KCI Citation Count: 2
Author Park, Yeon Hee
Jung, Woojin
Kim, Youngji
AuthorAffiliation 1 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Internal Medicine, Incheon Sarang Hospital, Incheon, Korea
AuthorAffiliation_xml – name: Department of Internal Medicine, Incheon Sarang Hospital, Incheon, Korea
– name: 1 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Youngji
  surname: Kim
  fullname: Kim, Youngji
  organization: Department of Internal Medicine, Incheon Sarang Hospital, Incheon, Korea
– sequence: 2
  givenname: Woojin
  surname: Jung
  fullname: Jung, Woojin
  organization: Department of Internal Medicine, Incheon Sarang Hospital, Incheon, Korea
– sequence: 3
  givenname: Yeon Hee
  surname: Park
  fullname: Park, Yeon Hee
  organization: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26155297$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002001081$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kc1u1DAUhS1URKeFB2CDsmSTYDt2bG-QhmmBkYpAqKytG8eZus3Yg-0U-vZ4OlB-FqyuJX_nnKt7TtCRD94i9JzghmEmX133pqGY8IbIhjZE8UdoQbGitVIYH6EFEa2sO8G7Y3SS0jXGHWuFeIKOaUc4p0os0ObMxi3ksL0LyWWXKvBD9QnM5DJ8t1O99sNs7FCt5gzehjlVZ3HeVOdx3mUXfLVMKRgHuSDfXL6qPtgMKUN2pnoTbXlWK_DGxqfo8QhTss9-zlP05e355ep9ffHx3Xq1vKgNa2muezb2_SgxBmUF6YWk0JKe2Y6rQUkQRjE7yrL8YDvKQIwDDFxy3jMyCiCsPUUvD74-jvrGOB3A3c9N0DdRLz9frjVTxU4V9PUB3c391g7G-hxh0rvothDv7oV__3h3VWxuNWMKU4F_Z-1i-DrblPXWJWOn6XApTTrFiWSlkYK--DPrIeRXEQUgB8DEkFK04wNCsN6XrUvZel-2JlJTXcouGvGPxrj96cN-XTf9R_kD-s2xfw
CitedBy_id crossref_primary_10_1007_s10549_017_4566_0
crossref_primary_10_1515_folmed_2017_0003
crossref_primary_10_1007_s40278_015_3676_x
crossref_primary_10_1007_s13691_023_00646_2
Cites_doi 10.1001/archderm.1980.01640270055013
10.2332/allergolint.55.27
10.1093/rheumatology/ket279
10.7326/0003-4819-84-1-68
10.1136/ard.60.5.433
10.1097/ACI.0b013e32832d565c
10.1093/jnci/82.15.1247
10.1111/j.1398-9995.2011.02677.x
10.1056/NEJMcp1104080
10.1001/jama.1986.03380240052027
ContentType Journal Article
Copyright 2015 Korean Breast Cancer Society. All rights reserved. 2015
Copyright_xml – notice: 2015 Korean Breast Cancer Society. All rights reserved. 2015
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4048/jbc.2015.18.2.195
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-9900
EndPage 199
ExternalDocumentID oai_kci_go_kr_ARTI_496599
PMC4490270
26155297
10_4048_jbc_2015_18_2_195
Genre Case Reports
GroupedDBID ---
5-W
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
DU5
EF.
GROUPED_DOAJ
HYE
KQ8
M48
O5R
O5S
PGMZT
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c432t-b4fbbf800a9e71b782a31b4e659d98a7c94ef8155de624a7fdad5855b41f7a143
IEDL.DBID M48
ISSN 1738-6756
IngestDate Tue Nov 21 21:25:03 EST 2023
Thu Aug 21 18:36:43 EDT 2025
Thu Jul 10 23:10:12 EDT 2025
Thu Jan 02 23:02:59 EST 2025
Tue Jul 01 01:56:42 EDT 2025
Thu Apr 24 22:51:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Drug eruptions
Breast neoplasms
Immunity
Dermatomyositis
Paclitaxel
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c432t-b4fbbf800a9e71b782a31b4e659d98a7c94ef8155de624a7fdad5855b41f7a143
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
G704-SER000010237.2015.18.2.013
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4048/jbc.2015.18.2.195
PMID 26155297
PQID 1695184209
PQPubID 23479
PageCount 5
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_496599
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4490270
proquest_miscellaneous_1695184209
pubmed_primary_26155297
crossref_primary_10_4048_jbc_2015_18_2_195
crossref_citationtrail_10_4048_jbc_2015_18_2_195
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-06-01
PublicationDateYYYYMMDD 2015-06-01
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of breast cancer
PublicationTitleAlternate J Breast Cancer
PublicationYear 2015
Publisher Korean Breast Cancer Society
한국유방암학회
Publisher_xml – name: Korean Breast Cancer Society
– name: 한국유방암학회
References Abu-Shakra (10.4048/jbc.2015.18.2.195_ref8) 2001; 60
Rowinsky (10.4048/jbc.2015.18.2.195_ref10) 1990; 82
Bigby (10.4048/jbc.2015.18.2.195_ref4) 1986; 256
Barnes (10.4048/jbc.2015.18.2.195_ref2) 1976; 84
Franks (10.4048/jbc.2015.18.2.195_ref9) 2012; 32
Venalis (10.4048/jbc.2015.18.2.195_ref3) 2014; 53
Pectasides (10.4048/jbc.2015.18.2.195_ref6) 2006; 26
Schlapbach (10.4048/jbc.2015.18.2.195_ref12) 2011; 66
Callen (10.4048/jbc.2015.18.2.195_ref1) 1980; 116
Stern (10.4048/jbc.2015.18.2.195_ref5) 2012; 366
Rozieres (10.4048/jbc.2015.18.2.195_ref7) 2009; 9
Roujeau (10.4048/jbc.2015.18.2.195_ref11) 2006; 55
References_xml – volume: 116
  start-page: 295
  year: 1980
  ident: 10.4048/jbc.2015.18.2.195_ref1
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1980.01640270055013
– volume: 55
  start-page: 27
  year: 2006
  ident: 10.4048/jbc.2015.18.2.195_ref11
  publication-title: Allergol Int
  doi: 10.2332/allergolint.55.27
– volume: 53
  start-page: 397
  year: 2014
  ident: 10.4048/jbc.2015.18.2.195_ref3
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ket279
– volume: 26
  start-page: 2329
  year: 2006
  ident: 10.4048/jbc.2015.18.2.195_ref6
  publication-title: Anticancer Res
– volume: 84
  start-page: 68
  year: 1976
  ident: 10.4048/jbc.2015.18.2.195_ref2
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-84-1-68
– volume: 60
  start-page: 433
  year: 2001
  ident: 10.4048/jbc.2015.18.2.195_ref8
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.60.5.433
– volume: 9
  start-page: 305
  year: 2009
  ident: 10.4048/jbc.2015.18.2.195_ref7
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/ACI.0b013e32832d565c
– volume: 82
  start-page: 1247
  year: 1990
  ident: 10.4048/jbc.2015.18.2.195_ref10
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/82.15.1247
– volume: 32
  start-page: 1119
  year: 2012
  ident: 10.4048/jbc.2015.18.2.195_ref9
  publication-title: Anticancer Res
– volume: 66
  start-page: 1469
  year: 2011
  ident: 10.4048/jbc.2015.18.2.195_ref12
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2011.02677.x
– volume: 366
  start-page: 2492
  year: 2012
  ident: 10.4048/jbc.2015.18.2.195_ref5
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp1104080
– volume: 256
  start-page: 3358
  year: 1986
  ident: 10.4048/jbc.2015.18.2.195_ref4
  publication-title: JAMA
  doi: 10.1001/jama.1986.03380240052027
SSID ssj0064377
Score 1.9924494
Snippet Dermatomyositis (DM) is an idiopathic autoimmune connective disease characterized by muscles and skin inflammation of and a well-recognized association with...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 195
SubjectTerms Case Report
일반외과학
Title Dermatomyositis and Paclitaxel-Induced Cutaneous Drug Eruption Associated with Metastatic Breast Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/26155297
https://www.proquest.com/docview/1695184209
https://pubmed.ncbi.nlm.nih.gov/PMC4490270
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002001081
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Breast Cancer, 2015, 18(2), 74, pp.195-199
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBdtB2MvY99rtwUN9jSwsRTJtp7GlrZ0g4w9LNA3oc8sbeasjg3tf7872wnLCIM9GeOzjfTTSb_Tne4IeQeQZyZzeVLKzCVCgSoa6cpE-iI6EV2RBTzvPP2aX8zEl0t5eUA25a2GDlzvNe2wntSsXqa3N3cfQOGBv6YC085eWcxFyGTKypSnTMlDcg8WphxtsanYOhXQRdXVWilAx4En572Tc_8ndpapw6qO-xjo34GUf6xM54_Iw4FS0o_9GHhMDkL1hNyfDk7zp2R-irNvs_p51wVorampPP1mHKbnvg3LBKt3uODppAWiGFbtmp7W7Zye1W03ndANgiCCu7Z0GhqD55AWjn7CkPaGTnDo1M_I7Pzs--QiGeorJE6MeZNYEa2NwBiNCgWzwBXMmFkRcqm8Kk3hlAixBMLhQ86FKaI3HqwLaQWLhQGi9ZwcVasqvCTU86w0yvMIbBAIWm6ZjTZGb63k0o6LY5JtulO7Ifk41sBYajBCEAENCGhEQLNScw0IHJP321d-9Zk3_iX8FjDS126hMV82XucrfV1rsAo-6y4nvgKZDYIadAgdI32vapYDzywFz0DmRY_o9pccHbdcQQuKHay3Avi_3SfV4keXp1sIBUZ_dvI_DXlFHuB9H4z2mhw1dRveAO1p7KjbLhh1Q3rU7Ur9Bo49AmE
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dermatomyositis+and+Paclitaxel-Induced+Cutaneous+Drug+Eruption+Associated+with+Metastatic+Breast+Cancer&rft.jtitle=Journal+of+breast+cancer&rft.au=Kim%2C+Youngji&rft.au=Jung%2C+Woojin&rft.au=Park%2C+Yeon+Hee&rft.date=2015-06-01&rft.issn=1738-6756&rft.eissn=2092-9900&rft.volume=18&rft.issue=2&rft.spage=195&rft_id=info:doi/10.4048%2Fjbc.2015.18.2.195&rft.externalDBID=n%2Fa&rft.externalDocID=10_4048_jbc_2015_18_2_195
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6756&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6756&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6756&client=summon